Visualizing ALS disease
- D-CHAB
- IPW
Prof. Ametamey and collaborators developed a new marker that selectively targets a receptor which is upregulated in neuroinflammatory diseases such as amyotrophic lateral sclerosis (ALS)
by
Joachim Schnabl
Reference
external pageSynthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor:call_made Slavik R, Müller Herde A, Bieri D, Weber M, Schibli R, Krämer SD, Ametamey SM, Mu L. European Journal of Medicinal Chemistry, 2015, 92: 554-564.